Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × asciminib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Myeloproliferative Disorders 2 Leukemia, Myeloid, Chronic-Phase 2 Malignant Solid Tumors 1 Leukemia, Myeloid 1 Leukemia 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

pembrolizumab 5 Injections 4 Bevacizumab 4 Pemetrexed 3 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 Docetaxel 3 Carboplatin 3 trifluridine tipiracil drug combination 2 Paclitaxel 2 Irinotecan 2 Cetuximab 2 tislelizumab 1 sotorasib 1 palbociclib 1 olaparib 1 netrin-1 inhibitor NP137 1 fludarabine 1 cemiplimab 1 Panitumumab 1 Nivolumab 1 Itraconazole 1 HMPL-013 1 Fulvestrant 1 Etoposide 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡